235 Studies Now Enrolling
Menu
Search
Status
Medical Condition
- Show all (89)
- Autoimmune Disorders (1)
- Blood Disorders (3)
- Bone & Muscle (1)
- Cancer (18)
- COVID-19 (Coronavirus) (4)
- Diabetes (2)
- Endocrine & Metabolic Disease (3)
- Hair and Skin Disorders (1)
- Healthy Volunteers (12)
- Heart Disease (17)
- (-) Kidney Disease (1)
- Liver Disease (2)
- Lung Disease (2)
- Neurological Disorders (3)
- Nutrition (2)
- Obesity (2)
- Obstetrics & Gynecology (3)
- Pediatrics (7)
- Surgery (2)
- Transplant (3)
Displaying 1 - 3 of 3
Condition: Kidney Disease
Investigator: Jai Radhakrishnan, MD
Status: Closed
This study is for patients with autosomal dominant polycystic kidney disease (ADPKD). The purpose of this study is to test the effectiveness of a study drug called tolvaptan. Tolvaptan continues to be studied in this trial as a possible treatment for ADPKD. ADPKD is a disease that causes kidney cysts (cyst are like fluid-filled balloons), worsening kidney…
Condition: Cancer / Uveal Melanoma
Investigator: Richard Carvajal, MD
Status: Closed
You are invited to join voluntarily in a clinical research study to find out if the drug LXS196 alone or in combination with HDM201 is safe and has beneficial effects in people who have metastatic uveal melanoma. The purpose of this study is to determine the highest dose of LXS196 that can be given safely without unacceptable…
Condition: Cancer / Uveal Melanoma
Investigator: Richard Carvajal, MD
Status: Closed
The purpose of this study is evaluate the benefits and safety of using the combination of drugs, AEB071 and BYL719 to treat patients with an advanced form of uveal melanoma. The study will have two parts. The first part twill test different dose levels of each drug.Once the highest safe dose level is found, another group of…